Evidence map›Paper›PMID 36194494›Full record

ArticleJCI insight2022

IRF4 expression by lung dendritic cells drives acute but not Trm cell-dependent memory Th2 responses.

Daniel F Camacho, Tania E Velez, Maile K Hollinger, Esther Wang, Chanie L Howard, Eli P Darnell, Domenick E Kennedy, Paulette A Krishack, Cara L Hrusch, Marcus R Clark and 2 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Immunotherapy for asthma.Cellular & molecular immunology · 2025
    Review
  2. The immunology of asthma.Nature immunology · 2025
    Review
  3. Lung-resident memory CD4+ T cells are dependent on Batf3.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Emerging roles of MITF as a crucial regulator of immunity.Experimental & molecular medicine · 2024
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Daniel F CamachoCommittee on Immunology and Department of Medicine and.
Tania E VelezCommittee on Immunology and Department of Medicine and.
Maile K HollingerCommittee on Immunology and Department of Medicine and.
Esther WangPritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.
Chanie L HowardCommittee on Immunology and Department of Medicine and.
Eli P DarnellMassachusetts General Hospital, Boston, Massachusetts, USA.
Domenick E KennedyCommittee on Immunology and Department of Medicine and.
Paulette A KrishackCommittee on Immunology and Department of Medicine and.
Cara L HruschCommittee on Immunology and Department of Medicine and.
Marcus R ClarkCommittee on Immunology and Department of Medicine and.
James J MoonMassachusetts General Hospital, Boston, Massachusetts, USA.
Anne I SperlingCommittee on Immunology and Department of Medicine and.
University of Chicago · USUniversity of Virginia · USHarvard University · USMassachusetts General Hospital · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ANDREW D LUSTER · 1991 to 2026
$35.3M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
RESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
Tetramer CoreU19AI095261 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VON ANDRIAN, ULRICH H · 2011 to 2015
$10.8M
Project-003U19AI162310 · NIAID · UNIVERSITY OF CHICAGO · PI Carole Ober · 2021 to 2026
$10.6M
University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Functional Genomics of IL-33 Expression and Asthma RiskR01HL118758 · NHLBI · UNIVERSITY OF CHICAGO · PI NOBREGA, MARCELO A., SPERLING, ANNE I. · 2014 to 2017
$2.9M
IRF4+ respiratory dendritic cells in type 2 inflammatory responsesR01AI125644 · NIAID · UNIVERSITY OF CHICAGO · PI SPERLING, ANNE I. · 2017 to 2021
$2.1M
IRF4+ respiratory dendritic cells in type 2 inflammatory responsesF30HL137309 · NHLBI · UNIVERSITY OF CHICAGO · PI CAMACHO, DANIEL FERNANDO · 2017 to 2020
$199k
Inhibition of Th2 responses by secreted components of a common farm bacteriumF31HL156659 · NHLBI · UNIVERSITY OF CHICAGO · PI HOLLINGER, MAILE KANANIOKALA · 2021 to 2023
$94k
NHLBI NIH HHS F30 HL137309NHLBI NIH HHS F31 HL156659NHLBI NIH HHS R01 HL118758NHLBI NIH HHS T32 HL007605NIAID NIH HHS R01 AI125644NIAID NIH HHS T32 AI007090NIAID NIH HHS U19 AI095261NIAID NIH HHS U19 AI162310NIDDK NIH HHS P30 DK043351NIGMS NIH HHS R25 GM109439NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

Expression of the transcription factor interferon regulatory factor 4 (IRF4) is required for the development of lung conventional DCs type 2 (cDC2s) that elicit Th2 responses, yet how IRF4 functions in lung cDC2s throughout the acute and memory allergic response is not clear. Here, we used a mouse model that loses IRF4 expression after lung cDC2 development to demonstrate that mice with IRF4-deficient DCs display impaired memory responses to allergen. This defect in the memory response was a direct result of ineffective Th2 induction and impaired recruitment of activated effector T cells to the lung after sensitization. IRF4-deficient DCs demonstrated defects in their migration to the draining lymph node and in T cell priming. Finally, T cells primed by IRF4-competent DCs mediated potent memory responses independently of IRF4-expressing DCs, demonstrating that IRF4-expressing DCs are not necessary during the memory response. Thus, IRF4 controlled a program in mature DCs governing Th2 priming and effector responses, but IRF4-expressing DCs were dispensable during tissue-resident memory T cell-dependent memory responses.

Indexed as

Dendritic CellsInterferon Regulatory FactorsMemory T CellsAllergensAnimalsGene Expression RegulationImmunologic MemoryLungMiceTh2 CellsAllergensInterferon Regulatory FactorsAsthmaDendritic cellsImmunologyTh2 response

Identifiers

PMID36194494
PMCPMC9675458
OpenAlexW4301178738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.